American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$706M |
| 2 |
Kenvue
KVUE
|
+$193M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 4 |
Entegris
ENTG
|
+$160M |
| 5 |
Merck
MRK
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$301M |
| 2 |
Visa
V
|
+$269M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 4 |
Allstate
ALL
|
+$172M |
| 5 |
Air Products & Chemicals
APD
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.13% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Citizens Financial Services
CZFS
$393M
| $365K | ﹤0.01% |
7,565
+503
| +7% | +$25.5K |
|
2527
Hippo Holdings
HIPO
$869M
| $363K | ﹤0.01% |
19,861
+5,182
| +35% | +$63.8K |
|
|
NVRO
2528
DELISTED
NEVRO CORP.
NVRO
| $363K | ﹤0.01% |
25,104
+7,920
| +46% | +$131K |
|
2529
Empire State Realty Trust
ESRT
$836M
| $361K | ﹤0.01% |
35,633
+16,612
| +87% | +$164K |
|
|
CBD
2530
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $361K | ﹤0.01% |
572,936
+781
| +0.1% | +$575 |
|
2531
Invivyd
IVVD
$202M
| $360K | ﹤0.01% |
+81,113
| New | +$335K |
|
2532
Enanta Pharmaceuticals
ENTA
$391M
| $360K | ﹤0.01% |
20,605
+9,975
| +94% | +$132K |
|
2533
Blackbaud
BLKB
$2.1B
| $359K | ﹤0.01% |
4,848
-258,643
| -98% | -$19.8M |
|
2534
Fresenius Medical Care
FMS
$12.6B
| $359K | ﹤0.01% |
18,601
| – | – |
|
2535
Group 1 Automotive
GPI
$3.14B
| $358K | ﹤0.01% |
1,225
-3,314
| -73% | -$905K |
|
|
TERN
2536
DELISTED
Terns Pharmaceuticals
TERN
| $357K | ﹤0.01% |
54,484
+26,050
| +92% | +$170K |
|
2537
LifeVantage
LFVN
$81.9M
| $355K | ﹤0.01% |
58,728
| – | – |
|
|
AGR
2538
DELISTED
Avangrid, Inc.
AGR
| $355K | ﹤0.01% |
9,743
+657
| +7% | +$21.5K |
|
|
ALEX
2539
DELISTED
Alexander & Baldwin
ALEX
| $354K | ﹤0.01% |
21,516
+2,138
| +11% | +$36.8K |
|
2540
Grid Dynamics Holdings
GDYN
$644M
| $354K | ﹤0.01% |
28,798
-121
| -0.4% | -$1.58K |
|
2541
Replimune Group
REPL
$1.42B
| $353K | ﹤0.01% |
43,198
+10,332
| +31% | +$84.7K |
|
|
DAY
2542
DELISTED
Dayforce
DAY
| $353K | ﹤0.01% |
5,324
| – | – |
|
2543
Boston Omaha
BOC
$431M
| $351K | ﹤0.01% |
22,728
+4,931
| +28% | +$77.6K |
|
|
ZYXI
2544
DELISTED
Zynex
ZYXI
| $350K | ﹤0.01% |
28,295
+6,992
| +33% | +$83.9K |
|
2545
Cogent Biosciences
COGT
$6.47B
| $350K | ﹤0.01% |
52,029
+1,052
| +2% | +$6.5K |
|
2546
Copel
ELPC
$7.87B
| $349K | ﹤0.01% |
51,839
| – | – |
|
2547
Larimar Therapeutics
LRMR
$444M
| $346K | ﹤0.01% |
45,636
+34,120
| +296% | +$266K |
|
2548
Crawford & Co Class B
CRD.B
$585M
| $345K | ﹤0.01% |
38,033
+22,502
| +145% | +$248K |
|
2549
Neurogene
NGNE
$713M
| $343K | ﹤0.01% |
+6,747
| New | +$225K |
|
2550
Leonardo DRS
DRS
$11.9B
| $343K | ﹤0.01% |
15,535
+554
| +4% | +$11.5K |
|
Similar funds
American Century Companies's Q1 2024 Portfolio in Review
As of Q1 2024, American Century Companies held 2,999 positions worth $159B, up 9.4% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
American Century Companies's Q1 2024 filing shows 122 new, 1,903 increased, 717 reduced and 75 closed positions. Its largest new stake was Bombardier Recreational Products: 736,453 shares worth $49.4M. The largest sale was Nike, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q1 2024 buy was Bombardier Recreational Products: 736,453 shares worth $49.4M.
- American Century Companies added most to Meta Platforms (Facebook) in Q1 2024, an estimated $706M increase.
- American Century Companies's biggest Q1 2024 reduction was Nike, cutting an estimated $301M.
- American Century Companies fully exited Mobileye in Q1 2024, selling an estimated $74.8M.
- American Century Companies's ten largest holdings make up 24% of its $159B portfolio in Q1 2024.
- American Century Companies opened 122 new positions and closed 75 in Q1 2024.
- American Century Companies's portfolio value rose 9.4% quarter-over-quarter to $159B.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.